Sign in

CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company

Personalis, Inc.

Sign in to watch
Ticker
PSNL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275411038
Phone
650-752-1300
Business address
6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$728,924
in 5 filings

Net −$728,924. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hall Christopher M −$583K Chief Executive Officer sold 15% of stake
  2. Chen Richard −$65K President and CMO sold 2% of stake
  3. Tachibana Aaron −$48K CFO AND COO sold 1% of stake
  4. Moore Stephen Michael −$34K SVP and Chief Legal Officer sold 2% of stake
Date Insider Transaction Shares Price Value Owned after
2021-05-15 West John Stephen President and CEO Grant or award +53,750 560,520
2021-05-15 West John Stephen President and CEO Grant or award · Stock Option (right to buy) +110,000 110,000
2021-05-15 West John Stephen President and CEO Grant or award · Stock Option (right to buy) +107,500 107,500
2021-05-14 MYERS WOODROW A JR Director Grant or award +2,736 5,346
2021-05-14 MYERS WOODROW A JR Director Grant or award · Stock Option (right to buy) +4,229 4,229
2021-05-14 EASTHAM KARIN Director Grant or award +2,736 2,736
2021-05-14 EASTHAM KARIN Director Grant or award · Stock Option (right to buy) +4,229 4,229
2021-05-14 MacQuitty Jonathan Director Grant or award +2,736 2,736
2021-05-14 MacQuitty Jonathan Director Grant or award · Stock Option (right to buy) +4,229 4,229
2021-05-14 LUDLUM KEN Director Grant or award +2,736 32,736
2021-05-14 LUDLUM KEN Director Grant or award · Stock Option (right to buy) +4,229 4,229
2021-05-14 Colowick Alan Director Grant or award +2,736 2,736
2021-05-14 Colowick Alan Director Grant or award · Stock Option (right to buy) +4,229 4,229
2021-05-14 BOWMAN A BLAINE Director Grant or award +2,736 2,736
2021-05-14 BOWMAN A BLAINE Director Grant or award · Stock Option (right to buy) +4,229 4,229
2021-04-01 Chen Richard Chief Scientific Officer Sale −21,223 $25.61 $544K 62,094
2021-04-01 Chen Richard Chief Scientific Officer Sale −6,260 $25.96 $163K 55,834
2021-04-01 Chen Richard Chief Scientific Officer Option exercise +12,517 $0.44 $6K 68,351
2021-04-01 Chen Richard Chief Scientific Officer Sale −12,517 $25.69 $322K 55,834
2021-04-01 Chen Richard Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −12,517 5,945

Page 16 of 23 · 444 trades